In a groundbreaking move, Endo, Inc. (OTCQX: NDOI) has launched the Spatial Computing Injection Simulator, marking a significant leap in medical education technology. This innovative tool, designed for hand specialists, creates an immersive learning environment using Apple Vision Pro, blending physical and digital elements to refine injection techniques.
The Spatial Computing Injection Simulator provides healthcare providers with a 20-minute immersive session designed to enhance their skills in administering XIAFLEX®, Endo’s FDA-approved nonsurgical treatment for Dupuytren’s contracture. During this hands-on training, practitioners can practice reconstitution and injection angles, observe procedures in real-time, and refine their injection technique using a lifelike hand model. The simulator also offers instruction on post-injection processes, ensuring a comprehensive learning experience. This innovative approach aims to improve the overall administration of the treatment, ultimately benefiting patients with Dupuytren’s contracture.
Endo’s initiative represents the first external spatial computing program launched by a pharmaceutical company. The technology has already generated significant interest at major medical conferences, with over 600 hand specialists trying the simulator at recent American Society for Surgery of the Hand (ASSH) and American Association for Hand Surgery (AAHS) annual meetings.
Dr. Jason Fanuele, an orthopedic surgeon specializing in hand and upper extremity, praised the technology: “This can make a huge difference for a hand surgeon or advanced practice provider in treating Dupuytren’s contracture nonsurgically. It’s the next-best thing to actually doing an injection in someone’s hand, maybe even better thanks to the educational resources and context”.
Endo has equipped its entire orthopedics sales team with the ability to offer this experience to healthcare providers, potentially revolutionizing how medical professionals learn and gain practical experience.
Dupuytren’s contracture, affecting an estimated 17 million Americans, is a progressive condition caused by collagen buildup in the hand. XIAFLEX® is a prescription medicine used to treat this condition in adults when a “cord” can be felt.
Justin Mattice, Senior Vice President & General Manager, Branded Specialty at Endo, emphasized the significance of this launch: “The Spatial Computing Injection Simulator represents a major leap forward in enhancing patient care through a groundbreaking educational tool. We’re proud to pioneer this capability in the pharmaceutical industry, paving the way for future innovations”.
As the pharmaceutical industry continues to evolve, Endo’s innovative approach to medical education sets a new standard, potentially influencing how healthcare professionals learn and practice in the future.
